Skip to main content
GliAlign Limited

Glialign Limited        

Cell therapy for peripheral nerve repair

Hundreds of thousands of people in the developed world are affected by severe peripheral nerve damage, resulting in paralysis and loss of sensation, and often accompanied by chronic pain. Current therapies are successful in fewer than half of cases. A cell therapy is under development at UCL for repair of severe peripheral nerve damage, mimicking nerve structure and better enabling functional recovery. Glialign was set-up in 2018 to take this technology forward and was funded by UCLTF, UK Innovation and Science: Seed Fund (UKI2S) and Innovate UK.